Table 33 In vitro cytotoxicity of peptide derivatives
From: A comprehensive review on biological activities of oxazole derivatives
Compd. | Cytotoxicity (GI50, µM) | ||
|---|---|---|---|
A-549 lung carcinoma NSCL | HT-29 colon carcinoma | MDA-MB-231 231breast adenocarcinoma | |
73 | 0.17 | 0.12 | 0.10 |
74 | 0.12 | 0.13 | 0.12 |